75 related articles for article (PubMed ID: 3043431)
1. PAF-acether and kidney pathology.
Pirotzky E; Braquet P
Prog Biochem Pharmacol; 1988; 22():168-80. PubMed ID: 3043431
[No Abstract] [Full Text] [Related]
2. [The role of the platelet-activating factor (PAF-acether) in renal pathology].
Pirotzky E; Braquet P
Presse Med; 1988 Apr; 17(14):692-5. PubMed ID: 2966954
[TBL] [Abstract][Full Text] [Related]
3. Antigen-initiated release of platelet-activating factor (PAF-acether) from mouse bone marrow-derived mast cells sensitized with monoclonal IgE.
Mencia-Huerta JM; Lewis RA; Razin E; Austen KF
J Immunol; 1983 Dec; 131(6):2958-64. PubMed ID: 6315819
[TBL] [Abstract][Full Text] [Related]
4. Biosynthesis of platelet-activating factor. VI. Precursor of platelet-activating factor and acetyltransferase activity in isolated rat kidney cells.
Pirotzky E; Ninio E; Bidault J; Pfister A; Benveniste J
Lab Invest; 1984 Nov; 51(5):567-72. PubMed ID: 6492758
[TBL] [Abstract][Full Text] [Related]
5. Paf-acether (platelet-activating factor).
Benveniste J
Bull Eur Physiopathol Respir; 1986; 22 Suppl 7():91-4. PubMed ID: 3955269
[No Abstract] [Full Text] [Related]
6. [Synthesis of paf-acether by E. coli K12].
Thomas Y; Denizot Y; Dassa E; Boullet C; Benveniste J
C R Acad Sci III; 1986; 303(17):699-702. PubMed ID: 3101984
[TBL] [Abstract][Full Text] [Related]
7. Involvement of platelet-activating factor in renal processes.
Pirotzky E; Egido J; Colliez P; Hosford D; Plante G; Braquet P
Adv Lipid Res; 1989; 23():277-93. PubMed ID: 2698054
[No Abstract] [Full Text] [Related]
8. Biosynthesis of Paf-acether (platelet-activating factor). VII. Precursors of Paf-acether and acetyl-transferase activity in human leukocytes.
Jouvin-Marche E; Ninio E; Beaurain G; Tence M; Niaudet P; Benveniste J
J Immunol; 1984 Aug; 133(2):892-8. PubMed ID: 6736649
[TBL] [Abstract][Full Text] [Related]
9. Biosynthesis of paf-acether. IX. Role for a phosphorylation-dependent activation of acetyltransferase in antigen-stimulated mouse mast cells.
Ninio E; Joly F; Hieblot C; Bessou G; Mencia-Huerta JM; Benveniste J
J Immunol; 1987 Jul; 139(1):154-60. PubMed ID: 3584983
[TBL] [Abstract][Full Text] [Related]
10. Hyperacute renal allograft rejection in the rabbit. The role of platelet-activating factor and of cationic proteins derived from polymorphonuclear leukocytes and from platelets.
Ito S; Camussi G; Tetta C; Milgrom F; Andres G
Lab Invest; 1984 Aug; 51(2):148-61. PubMed ID: 6379289
[TBL] [Abstract][Full Text] [Related]
11. Inflammatory characteristics of PAF-acether in the skin of experimental animals and man.
Archer CB; Page CP; Paul W; Morley J; MacDonald DM
Int J Tissue React; 1985; 7(5):363-5. PubMed ID: 3863807
[TBL] [Abstract][Full Text] [Related]
12. [Role of PAF-acether (platelet activating factor) in cardio-vascular pathology].
Gateau O
Arch Mal Coeur Vaiss; 1987 May; 80 Spec No():51-2. PubMed ID: 3117010
[No Abstract] [Full Text] [Related]
13. PAF-acether may not mediate the third pathway of platelet aggregation since self-desensitization reduces the effects of low thrombin but enhances those of convulxin.
Wal F; Joseph D; Touqui L; Vargaftig BB
Thromb Haemost; 1985 Feb; 53(1):99-104. PubMed ID: 3992525
[TBL] [Abstract][Full Text] [Related]
14. PAF-acether (platelet-activating factor).
Benveniste J
Adv Prostaglandin Thromboxane Leukot Res; 1989; 19():355-8. PubMed ID: 2526498
[No Abstract] [Full Text] [Related]
15. Properties of PAF-acether appropriate to a mediator of the inflammatory aspects of asthma.
Page CP; Archer CB; Guerreiro D; Morley J
Int J Tissue React; 1985; 7(5):351-4. PubMed ID: 4055261
[TBL] [Abstract][Full Text] [Related]
16. [Platelet activating factor (PAF) and kidney failure progression].
Camici M; Carpi A; Sagripanti A
Minerva Med; 1997 Sep; 88(9):329-34. PubMed ID: 9411309
[TBL] [Abstract][Full Text] [Related]
17. [PAF and diseases].
Oda M; Satouchi K; Saito K
Tanpakushitsu Kakusan Koso; 1991 Feb; 36(3):363-70. PubMed ID: 2024019
[No Abstract] [Full Text] [Related]
18. Lack of correlation between cytotoxicity of agonists and antagonists of platelet activating factor [paf-acether] in neoplastic cells and modulation of [3H]-paf-acether binding to platelets from humans in vitro.
Berdel WE; Korth R; Reichert A; Houlihan WJ; Bicker U; Nomura H; Vogler WR; Benveniste J; Rastetter J
Anticancer Res; 1987; 7(6):1181-7. PubMed ID: 3442414
[TBL] [Abstract][Full Text] [Related]
19. Paf-acether (platelet-activating factor).
Benveniste J
Adv Prostaglandin Thromboxane Leukot Res; 1985; 13():11-8. PubMed ID: 3159192
[No Abstract] [Full Text] [Related]
20. The potential role of basophilic leukocytes and mast cells.
Götze O
Nephrol Dial Transplant; 1994; 9 Suppl 2():57-9. PubMed ID: 7520557
[No Abstract] [Full Text] [Related]
[Next] [New Search]
